DarioHealth Corp.

DarioHealth Corp. is a leading global digital health company headquartered in New York, NY, focused on revolutionizing how individuals manage and improve their health across the chronic condition spectrum. The company's core mission is to empower people with chronic conditions to achieve better health outcomes through behavior change, leveraging a user-centric and data-driven approach.

DarioHealth provides a comprehensive, hyper-personalized digital health solution that addresses multiple chronic conditions, including diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. This integrated platform combines FDA-cleared connected hardware devices, an AI-powered technology platform, and personalized digital and human coaching services. The company delivers its solutions to a diverse market, including health plans, self-insured employers, healthcare providers, and direct-to-consumer channels.

As of early 2026, DarioHealth maintains a strong market position, underscored by over 100 peer-reviewed scientific studies validating its clinical effectiveness and a focus on a value-based pricing model. Recent notable developments include the reporting of its fourth quarter and full-year 2025 financial results, demonstrating improved workplace function through its digital behavioral health program, and the appointment of John R. Palumbo to its Board of Directors in April 2026 to support commercial scaling. Erez Raphael serves as the Chief Executive Officer. The company continues to expand its business-to-business-to-consumer (B2B2C) model, targeting employers and health plans.